No Data
No Data
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
An Intrinsic Calculation For Altimmune, Inc. (NASDAQ:ALT) Suggests It's 39% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Altimmune fair value estimate is US$14.49 Altimmune's US$8.89 share price signals that it might be 39% undervalued Analyst price target fo
Analysts Are Bullish on Top Healthcare Stocks: Moderna (MRNA), Altimmune (ALT)
Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Kiora Pharmaceuticals (KPRX) and Actinium Pharmaceuticals (ATNM)
Q4 2023 Altimmune Inc Earnings Call
Buy Rating Affirmed for Altimmune as Pemvidutide Shows Promising Weight Loss and Lean Mass Preservation
No Data